Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Journal of the American College of Cardiology|April 5, 2011
No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection studyJemma C Hopewell, Sarah Parish, Robert Clarke, et al.
Ophthalmology|January 18, 2024
ASCEND-Eye: Effects of Aspirin on Diabetic RetinopathyEmily L Sammons, Georgina Buck, Louise J Bowman, et al.
Lancet (London, England)|November 12, 2010
Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial, Jane Armitage, Louise Bowman, et al.
Clinical Therapeutics|August 27, 2019
Serious Adverse Effects of Extended-release Niacin/Laropiprant: Results From the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) TrialRichard Haynes, Elsa Valdes-Marquez, Jemma C Hopewell, et al.
Circulation|April 28, 2012
Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection StudySarah Parish, Alison Offer, Robert Clarke, et al.
Trials|March 4, 2023
Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trialSarah Parish, Georgina Buck, Theingi Aung, et al.
International Journal of Epidemiology|July 28, 2006
Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'Bernard Keavney, John Danesh, Sarah Parish, et al.
Circulation. Cardiovascular Quality and Outcomes|July 14, 2016
Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin With Laropiprant on Health and Healthcare CostsSeamus Kent, Richard Haynes, Jemma C Hopewell, et al.
Trials|December 7, 2019
Investigating modifications to participant information materials to improve recruitment into a large randomized trial, Richard Haynes, Fang Chen, et al.
European Heart Journal|February 28, 2008
Biomarkers of inflammation predict both vascular and non-vascular mortality in older menRobert Clarke, Jonathan R Emberson, Elizabeth Breeze, et al.
Pageof 9